Chronic Pain

LAS VEGAS —Patients with pain combined with opioid use disorder could realize benefits from cognitive behavioral therapy, Ravi Prasad, PhD, said at PAINWeek 2022.

LAS VEGAS — The majority of opioid-related overdoses can be linked to illicit heroin and fentanyl, not opioids prescribed by physicians to patients with legitimate chronic pain, according to a presentation during PAINWeek 2022.

LAS VEGAS — Recognition of the fear avoidance model, which is how one develops chronic pain through avoidant behavior, can help clinicians treat pain in patients, according to a presenter at PAINWeek 2022.

Following a hybrid conference last year, PAINWeek 2022 will be back in full swing, as this year’s meeting will be fully in-person.

The American Society of Interventional Pain Physicians and the Interventional Pain Management Tracks will return to the PAINWeek National Conference, taking place Sept. 6-9 in Las Vegas.

Using artificial intelligence to facilitate cognitive behavioral therapy for chronic pain can provide outcomes that are as good as typical interventions while requiring less time with a therapist, according to researchers.

In a Danish cohort, use of medical cannabis for chronic pain was associated with an 83% increased risk for arrhythmias, researchers reported at the European Society of Cardiology Congress.

The FDA has granted premarket approval for Abbott’s Proclaim Plus spinal cord stimulation system, which can treat chronic pain across up to six areas of the body and is programmable to adjust to a person’s needs, the company announced in a release.

Following the release of opioid prescription guidance from the CDC in 2016, nonopioid pain prescriptions increased every year through 2019, researchers wrote in JAMA Network Open.

Central sensitization may be an important underlying factor that complicates the treatment of chronic pain and opioid use disorders, researchers wrote in PAIN Reports.